Stereotactic Body Radiation Therapy Causes Acceptable Levels of Toxicity: Presented at ELCC

GENEVA -- April 29, 2008 -- The nonfatal toxicity that sometimes accompanies stereotactic body radiation therapy (SBRT) appears to be an acceptable adverse effect of the treatment in patients with early-stage non-small-cell lung cancer (NSCLC), researchers reported here at the 1st European Lung Cancer Conference (ELCC).

Robert D. Timmerman, MD, Radiation Oncologist, University of Texas Southwestern Medical Center, Dallas, Texas, and collaborators in the Radiation Therapy Oncology Group 0236 protocol studied a cohort of 59 patients between May 2004 and October 2006. Subjects in this phase 3 trial had inoperable NSCLC and had no other planned therapy.

source: Doctors Guide